Risk factors and preventive measures for abnormal blood pressure during hemodialysis filtration for patients with sepsis

  • Chunfang Zhang Aviation General Hospital, Department of Critical Care Medicine, Beijing, China
  • Tingting Lin Forth Hospital of Changsha, Department of Critical Care of Medicine, Changsha, Hunan Province, China
  • Yu Xia 7th Medical Center of PLA General Hospital, Department of Emergency, Beijing, China
  • Daowei Zhang Nantong University, Faculty of Medicine, Taizhou People’s Hospital, Department of Intensive Care Unit, Taizhou, Jiangsu Province, China
Keywords: acute kidney injury;, blood pressure;, blood pressure determination;, dialysis;, prognosis;, risk factors;, sepsis.

Abstract


Background/Aim. Hemodialysis filtration (HDF) plays an extremely important role in treating patients with sepsis and subsequent acute renal failure. However, abnormal blood pressure (ABP) during HDF badly influences the prognosis and increases all-cause mortality in patients with sepsis. The aim of the study was to investigate risk factors and preventive measures of ABP during HDF for patients with sepsis. Methods. A total of 145 patients with sepsis undergoing HDF were included in this study, and they were divided into two groups: the normal blood pressure (NBP) group (n = 89) and the ABP group (n = 56). Their clinical data were collected, and the independent influencing factors for ABP during HDF were assessed by univariate and multivariate logistic regression analyses. A nomogram model for prediction was constructed based on the results of multivariate analysis, and its discrimination and consistency were assessed using receiver operating characteristic and calibration curves. The Kaplan-Meier method was used to plot the survival curve to evaluate the prognosis 28 days after HDF. Results. Multivariate logistic regression analysis revealed that age, blood calcium, fasting plasma glucose, intact parathyroid hormone, ultrafiltration volume, and ultrafiltration rate were independent risk factors, whereas albumin was a protective factor for ABP during HDF (p < 0.05). The nomogram model exhibited a good fitting effect, with high discrimination and accuracy. Kaplan-Meier survival analysis showed that the NBP group had a significantly higher 28-day survival rate than that of ABP (88.76% vs. 73.21%) (< 0.05). Conclusion. The constructed risk model is suitable for identifying high-risk groups and provides a reference for effective prevention and treatment, to lower the incidence rate of ABP and improve the prognosis.

Author Biography

Daowei Zhang, Nantong University, Faculty of Medicine, Taizhou People’s Hospital, Department of Intensive Care Unit, Taizhou, Jiangsu Province, China

Background/Aim. Hemodialysis filtration (HDF) plays an extremely important role in treating patients with sepsis and subsequent acute renal failure. However, abnormal blood pressure (ABP) during HDF badly influences the prognosis and increases all-cause mortality in patients with sepsis. The aim of the study was to investigate risk factors and preventive measures of ABP during HDF for patients with sepsis. Methods. A total of 145 patients with sepsis undergoing HDF were included in this study, and they were divided into two groups: the normal blood pressure (NBP) group (n = 89) and the ABP group (n = 56). Their clinical data were collected, and the independent influencing factors for ABP during HDF were assessed by univariate and multivariate logistic regression analyses. A nomogram model for prediction was constructed based on the results of multivariate analysis, and its discrimination and consistency were assessed using receiver operating characteristic and calibration curves. The Kaplan-Meier method was used to plot the survival curve to evaluate the prognosis 28 days after HDF. Results. Multivariate logistic regression analysis revealed that age, blood calcium, fasting plasma glucose, intact parathyroid hormone, ultrafiltration volume, and ultrafiltration rate were independent risk factors, whereas albumin was a protective factor for ABP during HDF (p < 0.05). The nomogram model exhibited a good fitting effect, with high discrimination and accuracy. Kaplan-Meier survival analysis showed that the NBP group had a significantly higher 28-day survival rate than that of ABP (88.76% vs. 73.21%) (< 0.05). Conclusion. The constructed risk model is suitable for identifying high-risk groups and provides a reference for effective prevention and treatment, to lower the incidence rate of ABP and improve the prognosis.

References

Addissouky TA, El Tantawy El Sayed I, Ali MMA, Wang Y, El Baz A, Khalil AA, et al. Molecular Pathways in Sepsis Patho-genesis: Recent Advances and Therapeutic Avenues. J Cell Immunol 2023; 5(6): 174–83.

Rose N, Matthäus-Krämer C, Schwarzkopf D, Scherag A, Born S, Reinhart K, et al. Association between sepsis incidence and re-gional socioeconomic deprivation and health care capacity in Germany - an ecological study. BMC Public Health 2021; 21(1): 1636.

Poston JT, Koyner JL. Sepsis associated acute kidney injury. BMJ 2019; 364: k4891.

Xu J. A review: continuous renal replacement therapy for sep-sis-associated acute kidney injury. All Life 2023; 16: 2163305.

Rajdev K, Leifer L, Sandhu G, Mann B, Pervaiz S, Habib S, et al. Fluid resuscitation in patients with end-stage renal disease on hemodialysis presenting with severe sepsis or septic shock: A case control study. J Crit Care 2020; 55: 157–62.

Chen Z, Sun F, Shen Y, Ma L, Liu J, Zhou Y. Impact of Dialy-sate Sodium Concentration Lowering on Home Blood Pres-sure Variability in Hemodialysis Patients. Ther Apher Dial 2019; 23(2): 153–9.

Guo L, Ji Y, Sun T, Liu Y, Jiang C, Wang G, et al. Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path. Rev Cardiovasc Med 2024; 25(6): 232.

Kuipers J, Verboom LM, Ipema KJR, Paans W, Krijnen WP, Gail-lard CAJM, et al. The prevalence of intradialytic hypotension in patients on conventional hemodialysis: a systematic review with meta-analysis. Am J Nephrol 2019; 49(6): 497–506.

Mennuni S, Rubattu S, Pierelli G, Tocci G, Fofi C, Volpe M. Hy-pertension and kidneys: unraveling complex molecular mecha-nisms underlying hypertensive renal damage. J Hum Hypertens 2014; 28(2): 74–9.

Bellomo R, Kellum JA, Ronco C, Wald R, Martensson J, Maiden M, et al. Acute kidney injury in sepsis. Intensive Care Med 2017; 43(6): 816–28.

Hunt A. Sepsis: an overview of the signs, symptoms, diagnosis, treatment and pathophysiology. Emerg Nurse 2019; 27(5): 32–41.

Maneta E, Aivalioti E, Tual-Chalot S, Emini Veseli B, Gatsiou A, Stamatelopoulos K, et al. Endothelial dysfunction and immuno-thrombosis in sepsis. Front Immunol 2023; 14: 1144229.

Tsevi YM, Dolaama B, Tona KG, Tevi AA, Affanou EC, Amede AD, et al. Chronic renal failure and hemodialysis in Lomé: are patients on haemodialysis and their entourage well informed? Pan Afr Med J 2021; 39: 85. (French)

Latha Gullapudi VR, White K, Stewart J, Stewart P, Eldehni MT, Taal MW, et al. An analysis of frequency of continuous blood pressure variation and haemodynamic responses during hae-modialysis. Blood Purif 2022; 51(5): 435-49.

Jeong HY, Kim HJ, Han M, Seong EY, Song SH. Dialysis unit blood pressure two hours after hemodialysis is useful for pre-dicting home blood pressure and ambulatory blood pressure in maintenance hemodialysis patients. Ther Apher Dial 2022; 26(1): 103–14.

Chen TK, Knicely DH, Grams ME. Chronic Kidney Disease Di-agnosis and Management: A Review. JAMA 2019; 322(13): 1294–304.

Okpa HO, Effa EE, Oparah SK, Chikezie JA, Bisong EM, Mbu PN, et al. Intradialysis blood pressure changes among chronic kidney disease patients on maintenance haemodialysis in a ter-tiary hospital south - south Nigeria: a 2 year retrospective study. Pan Afr Med J 2019; 33: 91.

Pedreros-Rosales C, Jara A, Lorca E, Mezzano S, Pecoits-Filho R, Herrera P. Unveiling the clinical benefits of high-volume he-modiafiltration: Optimizing the removal of medium-weight uremic toxins and beyond. Toxins 2023; 15: 531.

Tajbakhsh A, Kovanen PT, Rezaee M, Banach M, Sahebkar A. Ca2+ Flux: Searching for a Role in Efferocytosis of Apoptot-ic Cells in Atherosclerosis. J Clin Med 2019; 8(12): 2047.

Iida M, Harada S, Takebayashi T. Application of Metabolomics to Epidemiological Studies of Atherosclerosis and Cardiovas-cular Disease. J Atheroscler Thromb 2019; 26(9): 747-57.

Roszkowska-Blaim M, Skrzypczyk P, Jander A, Tkaczyk M, Bałasz-Chmielewska I, Żurowska A, et al. Effect of hypertension and antihypertensive medications on residual renal function in children treated with chronic peritoneal dialysis. Adv Med Sci 2015; 60(1): 18–24.

Zhou X, Guo Y, Luo Y. The optimal range of serum intact par-athyroid hormone for a lower risk of mortality in the incident hemodialysis patients. Ren Fail 2021; 43(1): 599–605.

Kim TW, Chang TI, Kim TH, Chou JA, Soohoo M, Ravel VA, et al. Association of ultrafiltration rate with mortality in incident hemodialysis patients. Nephron 2018; 139(1): 13–22.

Published
2024/12/26
Section
Original Paper